Skip to main content
NCBI home page
British Medical Journal logoLink to British Medical Journal
. 1973 Dec 22;4(5894):695–701. doi: 10.1136/bmj.4.5894.695

Incidence of Anticonvulsant Osteomalacia and Effect of Vitamin D: Controlled Therapeutic Trial

Claus Christiansen, Paul Rødbro, Mogens Lund
PMCID: PMC1587877  PMID: 4776883

Abstract

The bone mineral content (B.M.C.) in both forearms (related to total body calcium) was measured by photon absorptiometry for a controlled therapeutic trial in a representative sample of epileptic outpatients, comprising 226 patients treated with one or two major anticonvulsant drugs (phenytoin, phenobarbitone, primidone).

Initially the mean B.M.C. value for all epileptic patients was 87% of normal. During treatment with 2,000 international units of vitamin D2 daily for three months an average B.M.C. increase of 4% was found, whereas the B.M.C. values remained unchanged in the placebo group and in the control groups. The incidence of hypocalcaemia and raised serum alkaline phosphatase was 12% and 43% respectively. The biochemical indices of osteomalacia were related to B.M.C. These results indicate that epileptic patients should be closely supervised for the occurrence of anticonvulsant osteomalacia, and, possibly, receive prophylactic treatment with vitamin D.

Full text

PDF
695

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berger G., Munde B. Knochenstrukturveränderungen bei antikonvulsiver Langzeitbehandlung. Dtsch Gesundheitsw. 1970 Aug 13;25(33):1549–1551. [PubMed] [Google Scholar]
  2. Cameron J. R., Mazess R. B., Sorenson J. A. Precision and accuracy of bone mineral determination by direct photon absorptiometry. Invest Radiol. 1968 May-Jun;3(3):141–150. doi: 10.1097/00004424-196805000-00001. [DOI] [PubMed] [Google Scholar]
  3. Christiansen C., Kristensen M., Rodbro P. Latent osteomalacia in epileptic patients on anticonvulsants. Br Med J. 1972 Sep 23;3(5829):738–739. doi: 10.1136/bmj.3.5829.738. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Christiansen C., Rodbro P., Lund M. Effect of vitamin D on bone mineral mass in normal subjects and in epileptic patients on anticonvulsants: a controlled therapeutic trial. Br Med J. 1973 Apr 28;2(5860):208–209. doi: 10.1136/bmj.2.5860.208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hahn T. J., Hendin B. A., Scharp C. R., Haddad J. G., Jr Effect of chronic anticonvulsant therapy on serum 25-hydroxycalciferol levels in adults. N Engl J Med. 1972 Nov 2;287(18):900–904. doi: 10.1056/NEJM197211022871803. [DOI] [PubMed] [Google Scholar]
  6. Hunter J., Maxwell J. D., Stewart D. A., Parsons V., Williams R. Altered calcium metabolism in epileptic children on anticonvulsants. Br Med J. 1971 Oct 23;4(5781):202–204. doi: 10.1136/bmj.4.5781.202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Jensen H., Christiansen C., Lindbjerg I. F., Munck O. The mineral content in bone. Measured by means of 27.5 keV radiation from 125I. Acta Radiol Suppl. 1972;313:214–220. [PubMed] [Google Scholar]
  8. Larsen N. E., Naestoft J., Hvidberg E. Rapid routine determination of some anti-epileptic drugs in serum by gas chromatography. Clin Chim Acta. 1972 Aug;40(1):171–176. doi: 10.1016/0009-8981(72)90266-5. [DOI] [PubMed] [Google Scholar]
  9. Linde J., Hansen J. M., Siersbaek-Nielsen K., Fuglsang-Frederiksen V. Vitamin D in patients on anticonvulsants. Br Med J. 1972 Dec 2;4(5839):547–547. doi: 10.1136/bmj.4.5839.547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Linde J., Molholm Hansen J., Siersbaek-Nielsen K., Fuglsang-Fredriksen V. Bone density in patients receiving long-term anticonvulsant therapy. Acta Neurol Scand. 1971;47(5):650–651. doi: 10.1111/j.1600-0404.1971.tb07517.x. [DOI] [PubMed] [Google Scholar]
  11. Lussier-Lazaroff J., Fletcher B. D. Rickets and anticonvulsant therapy in children: a roentgenologic investigation. J Can Assoc Radiol. 1971 Jun;22(2):144–147. [PubMed] [Google Scholar]
  12. Lässker G., Degen R., Köthe C. Ossification disturbances in children under antiepileptic treatment. Confin Neurol. 1971;33(1):55–66. doi: 10.1159/000103103. [DOI] [PubMed] [Google Scholar]
  13. MARSH W. H., FINGERHUT B., KIRSCH E. Adaptation of an alkaline phosphatase method for automatic colorimetric analysis. Clin Chem. 1959 Apr;5(2):119–126. [PubMed] [Google Scholar]
  14. Mazess R. B. Estimation of bone and skeletal weight by direct photon absorptiometry. Invest Radiol. 1971 Jan-Feb;6(1):52–60. doi: 10.1097/00004424-197101000-00008. [DOI] [PubMed] [Google Scholar]
  15. Ponchon G., DeLuca H. F. The role of the liver in the metabolism of vitamin D. J Clin Invest. 1969 Jul;48(7):1273–1279. doi: 10.1172/JCI106093. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Richens A., Rowe D. J. Disturbance of calcium metabolism by anticonvulsant drugs. Br Med J. 1970 Oct 10;4(5727):73–76. doi: 10.1136/bmj.4.5727.73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. WRIGHT J. A. TRINURIDE IN THE TREATMENT OF MAJOR EPILEPSY. Epilepsia. 1965 Mar;6:67–74. doi: 10.1111/j.1528-1157.1965.tb03352.x. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES